Health Care: Drugs

iBio Inc (IBIO: AMEX)

$1.5 n/a | n/a%
10/24/14 - 04:00 PM ET
Company Income Statement
Jun 2014 Jun 2013 Jun 2012 Jun 2011
Sales 205.00K 1.01M 1.28M 520.08K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 205.00K 1.01M 1.28M 520.08K
Selling, General, and Administrative Expenses 4.20M 4.24M 5.62M 7.09M
Research & Development 150.00K 3.43M 4.98M 3.08M
Operating Income before D & A (EBITDA) -4.14M -6.67M -9.33M -9.65M
Depreciation & Amortization 361.00K 338.00K 329.71K 376.81K
Interest Income 130.00K 9.00K 11.67K 12.62K
Other Income - Net 344.00K 550.00K 3.70M -2.45M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -4.03M -6.45M -5.94M -12.47M
Interest Expense 0.00 90.00K 62.85K 50.50K
Pre-Tax Income -4.03M -6.54M -6.01M -12.52M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -3.67M -6.20M -5.68M -12.14M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -3.67M -6.20M -5.68M -12.14M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -3.67M -6.20M -5.68M -12.14M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-3.67M -6.20M -5.68M -12.14M
Preferred Dividends
Net Income Available To Common -3.67M -6.20M -5.68M -12.14M
Basic EPS from Continuing Ops. -0.06 -0.13 -0.14 -0.39
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.06 -0.13 -0.14 -0.39
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.06 -0.13 -0.14 -0.39
Basic Normalized Net Income/Share -0.06 -0.13 -0.14 -0.39
EPS fr Continuing Ops. -0.06 -0.13 -0.14 -0.39
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.06 -0.13 -0.14 -0.39
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.06 -0.13 -0.14 -0.39
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.06 -0.13 -0.14 -0.39
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IBIO

Latest IBIO Headlines from TheStreet

More Financial News for IBIO

Press Releases for IBIO

See All Press Releases

Partner Headlines for IBIO

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter